- Thomson Reuters StreetEvents•18 days ago
Q4 2016 H Lundbeck A/S Earnings Call
- Reuters•last month
Danish drugmaker Lundbeck is betting that shark antibodies may offer a new way of getting drugs into the brain to fight Alzheimer's and other diseases, after successful early research with privately owned U.S. biotech firm Ossianix. The two companies said on Thursday that Lundbeck had made an undisclosed payment to Ossianix, which has labs in Britain, following experiments in mice showing the effective transfer of potential drugs across the blood-brain barrier. Getting modern large-molecule medicines across the barrier that protects the brain is a major challenge for drug developers.
- Business Wire•3 months agoCitizens United for Research in Epilepsy (CURE) and Lundbeck Announce National Launch of Education Enrichment Fund
Citizens United for Research in Epilepsy and Lundbeck today announced the launch of the CURE Education Enrichment Fund Scholarship Program, which is a one-time scholarship for people who are living with epilepsy, family members and caregivers.
LUN.CO : Summary for H. Lundbeck A/S - Yahoo Finance
H. Lundbeck A/S (LUN.CO)
Copenhagen - Copenhagen Delayed Price. Currency in DKK
Add to watchlist
|Day's Range||292.30 - 300.00|
|52 Week Range||209.40 - 307.40|
|PE Ratio (TTM)||47.70|
|Dividend & Yield||0.00 (0.00%)|
|1y Target Est||N/A|